Brendan O'Grady
2020
In 2020, Brendan O'Grady earned a total compensation of $4.1M as Executive Vice President, North America Commercial at Teva Pharmaceutical Industries, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $991,198 |
|---|---|
| Salary | $776,923 |
| Stock Awards | $2,299,991 |
| Other | $58,171 |
| Total | $4,126,283 |
O'Grady received $2.3M in stock awards, accounting for 56% of the total pay in 2020.
O'Grady also received $991.2K in non-equity incentive plan, $776.9K in salary and $58.2K in other compensation.
Rankings
In 2020, Brendan O'Grady's compensation ranked 2,756th out of 13,090 executives tracked by ExecPay. In other words, O'Grady earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,756 out of 13,090 | 79th |
Division Manufacturing | 1,053 out of 5,621 | 81st |
Major group Chemicals And Allied Products | 391 out of 2,254 | 83rd |
Industry group Drugs | 337 out of 1,954 | 83rd |
Industry Pharmaceutical Preparations | 245 out of 1,459 | 83rd |
Source: SEC filing on April 21, 2021.
O'Grady's colleagues
We found four more compensation records of executives who worked with Brendan O'Grady at Teva Pharmaceutical Industries in 2020.
2020
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2020
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2020
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2020
Eli Kalif
Teva Pharmaceutical Industries